Research location
Granada Hills
California, United States
Advertisement
Research activity in Granada Hills
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 50 trials and 52 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Granada Hills
50 linked trials · page 1 of 1A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityNCT07567001 · 2026-05-11 · 1 site observation
RECRUITING
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)NCT05485961 · 2024-04-27 · 1 site observation
RECRUITING
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsNCT06112418 · 2024-03-06 · 1 site observation
RECRUITING
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesNCT06334133 · 2024-06-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With AlbuminuriaNCT06150924 · 2023-12-14 · 1 site observation
COMPLETED
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant HypertensionNCT06153693 · 2023-11-22 · 2 site observations
COMPLETED
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionNCT05968430 · 2023-07-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care SettingNCT05348733 · 2022-06-13 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney DiseaseNCT05432167 · 2022-04-29 · 1 site observation
COMPLETED
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseaseNCT05099770 · 2022-01-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)NCT04968184 · 2021-11-05 · 2 site observations
TERMINATED
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT TrialNCT04847557 · 2021-04-20 · 1 site observation
COMPLETED
A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)NCT04519658 · 2020-10-12 · 1 site observation
COMPLETED
A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change DiseaseNCT04387448 · 2020-07-28 · 1 site observation
TERMINATED
Study of Verinurad in Heart Failure With Preserved Ejection FractionNCT04327024 · 2020-05-19 · 1 site observation
COMPLETED
A Phase 2b Diabetic Kidney Disease StudyNCT04170543 · 2019-11-18 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney DiseaseNCT04026165 · 2019-07-24 · 1 site observation
COMPLETED
A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®NCT03892889 · 2019-04-29 · 1 site observation
TERMINATED
Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)NCT03919994 · 2019-03-28 · 1 site observation
COMPLETED
Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)NCT02966028 · 2016-11-01 · 1 site observation
COMPLETED
Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine SystemNCT02722967 · 2016-03-01 · 1 site observation
COMPLETED
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase SchizophrenicsNCT02360319 · 2014-12-11 · 1 site observation
COMPLETED
Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney DiseaseNCT02177786 · 2014-06-01 · 1 site observation
COMPLETED
Family-Focused Therapy for Youth With Early-Onset Bipolar or Psychotic DisordersNCT02097563 · 2014-06-01 · 1 site observation
COMPLETED
A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller MedicationNCT01868061 · 2013-07-31 · 1 site observation
COMPLETED
A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)NCT01922037 · 2013-06-19 · 1 site observation
COMPLETED
The Management of Schizophrenia in Clinical Practice (MOSAIC)NCT01746134 · 2012-12-01 · 1 site observation
COMPLETED
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)NCT01621178 · 2012-07-01 · 1 site observation
COMPLETED
Effect of KB003 in Subjects With Asthma Inadequately Controlled by CorticosteroidsNCT01603277 · 2012-07-01 · 1 site observation
COMPLETED
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma MedicationsNCT01576718 · 2012-04-01 · 1 site observation
COMPLETED
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing SteroidsNCT01479621 · 2012-01-01 · 1 site observation
COMPLETED
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.NCT01475721 · 2011-11-18 · 1 site observation
COMPLETED
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years OldNCT01462344 · 2011-11-17 · 1 site observation
COMPLETED
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)NCT01235559 · 2010-12-01 · 1 site observation
COMPLETED
A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of SchizophreniaNCT01192880 · 2010-11-01 · 1 site observation
COMPLETED
Fall Epidemic Viral Pediatric StudyNCT01192178 · 2010-08-01 · 1 site observation
COMPLETED
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With PlaceboNCT01136382 · 2010-07-01 · 1 site observation
COMPLETED
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on LurasidoneNCT01173874 · 2010-07-01 · 1 site observation
COMPLETED
A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term TherapyNCT01125748 · 2010-05-01 · 1 site observation
COMPLETED
Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With SchizophreniaNCT01095562 · 2010-03-01 · 1 site observation
COMPLETED
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.NCT00616798 · 2008-03-01 · 1 site observation
COMPLETED
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.NCT00603382 · 2007-12-01 · 1 site observation
COMPLETED
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.NCT00603746 · 2007-12-01 · 1 site observation
COMPLETED
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.NCT00603278 · 2007-12-01 · 1 site observation
COMPLETED
Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.NCT00325689 · 2006-07-01 · 1 site observation
COMPLETED
The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate CancerNCT00295750 · 2006-02-01 · 1 site observation
COMPLETED
Promoting Adherence to Treatment in SchizophreniaNCT01125267 · 2003-04-01 · 1 site observation
COMPLETED
An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's TypeNCT00153010 · 2003-02-01 · 1 site observation
COMPLETED
Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeNCT00036114 · 2000-03-01 · 1 site observation
COMPLETED
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal WomenNCT00003906 · 1999-05-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.